Kindra Galloway
Family Medicine · Nampa, IDNPI 1366939423
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$851
- AbbVie$768
- Amgen$579
- Novo Nordisk$532
- Corcept Therapeutics$410
- AstraZeneca$340
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,866100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 51 | $851 |
| AbbVie | 41 | $768 |
| Amgen | 31 | $579 |
| Novo Nordisk | 36 | $532 |
| Corcept Therapeutics | 19 | $410 |
| AstraZeneca | 12 | $340 |
| Lilly USA, LLC | 16 | $296 |
| Bayer | 12 | $228 |
| GSK | 11 | $222 |
| Boehringer Ingelheim | 9 | $206 |
| Exact Sciences | 6 | $136 |
| Dexcom, Inc. | 6 | $135 |
| Sanofi-aventis U.S. LLC | 6 | $122 |
| Phathom Pharmaceuticals, Inc. | 6 | $120 |
| Johnson & Johnson | 6 | $107 |
| Novartis | 5 | $97 |
| Astellas Pharma US Inc | 3 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $73 |
| Medtronic | 3 | $52 |
| Organon | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Lucid Diagnostics Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Gilead | 2 | $28 |
| Mayne Pharma Commercial LLC | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $21 |
| BD | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Merck | 1 | $14 |
| Sonex Health, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,876 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 33 | $42,645 |
| FarxigaDapagliflozin Propanediol | 27 | $36,862 |
| OzempicSemaglutide | 17 | $25,572 |
| CaplytaLumateperone Tosylate | 14 | $20,954 |
| EliquisApixaban | 17 | $19,665 |
| JardianceEmpagliflozin | 12 | $18,396 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $16,329 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $11,929 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $5,144 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $5,089 |
| Levothyroxine Sodium | 256 | $3,555 |
| Gabapentin | 110 | $3,101 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,598 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $2,376 |
| Atorvastatin Calcium | 239 | $2,156 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $296 | $42,64533 claims |
| AstraZenecaFarxiga, Symbicort | $340 | $39,46038 claims |
| Novo NordiskOzempic | $532 | $25,57217 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $73 | $20,95414 claims |
| PfizerEliquis | $851 | $19,66517 claims |
| Boehringer IngelheimJardiance | $206 | $18,39612 claims |
| GSKTrelegy Ellipta | $222 | $16,32913 claims |
| AbbVieSynthroid | $768 | $2,06021 claims |
| Sanofi-aventis U.S. LLCLantus | $122 | $1,96117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 803 family medicine providers in Idaho.
Other family medicine in Nampa
- Bryan PogueNampa$8K
- Trent GilesNampa$8K
- Kenneth CongerSandpoint$266K
- David ButukMeridian$206K
- Anne BroadwayIdaho Falls$184K
- Timothy McHughMeridian$165K
- Phyllis YouBoise$88K
- Ralph SutherlinSt Maries$73K
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.